Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Gardellini

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|October 16, 2014
Plerixafor: what we still have to learnFrancesco Lanza, Angelo Gardellini, Daniele Laszlo, et al.
Access Microbiology|November 16, 2020
The first case of <i>Mycobacterium vaccae</i> sepsis in a non-Hodgkin lymphoma patient: biological understandings and clinical consequenciesPierluigi Congedo, Angelo Gardellini, Lucia Corich, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 17, 2022
Lichen planopilaris-like eruption in chronic myeloid leukemia patient during treatment with nilotinib as second-line therapyAngelo Gardellini, Francesca Guidotti, Michelle Zancanella, et al.
Blood Cells, Molecules & Diseases|October 29, 2021
Eltrombopag as second line treatment in patients with primary immune thrombocytopenia: A single center real life experienceAngelo Gardellini, Francesca Guidotti, Maddalena Feltri, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 16, 2013
Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: a case reportFederica Gigli, Angelo Gardellini, Aleksandra Babic, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 23, 2014
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphomaJuan Montoro, Giovanna Andreola, Angelo Gardellini, et al.
Vaccines|July 2, 2021
Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, ItalyMauro Turrini, Angelo Gardellini, Livia Beretta, et al.
Pharmacogenomics and Personalized Medicine|May 2, 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib MonotherapyMonica Bocchia, Angelo Michele Carella, Antonino Mulè, et al.
Acta Haematologica|September 18, 2024
Bosutinib Treatment of Chronic Myeloid Leukemia in LombardyAlessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, et al.
Cancer|March 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Francesca Palandri, Maurizio Martelli, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|October 16, 2014
Plerixafor: what we still have to learnFrancesco Lanza, Angelo Gardellini, Daniele Laszlo, et al.
Access Microbiology|November 16, 2020
The first case of <i>Mycobacterium vaccae</i> sepsis in a non-Hodgkin lymphoma patient: biological understandings and clinical consequenciesPierluigi Congedo, Angelo Gardellini, Lucia Corich, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 17, 2022
Lichen planopilaris-like eruption in chronic myeloid leukemia patient during treatment with nilotinib as second-line therapyAngelo Gardellini, Francesca Guidotti, Michelle Zancanella, et al.
Blood Cells, Molecules & Diseases|October 29, 2021
Eltrombopag as second line treatment in patients with primary immune thrombocytopenia: A single center real life experienceAngelo Gardellini, Francesca Guidotti, Maddalena Feltri, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|March 16, 2013
Efficacy of photopheresis extracorporeal procedure as single treatment for severe chronic GVHD: a case reportFederica Gigli, Angelo Gardellini, Aleksandra Babic, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|April 23, 2014
R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphomaJuan Montoro, Giovanna Andreola, Angelo Gardellini, et al.
Vaccines|July 2, 2021
Clinical Course and Risk Factors for In-Hospital Mortality of 205 Patients with SARS-CoV-2 Pneumonia in Como, Lombardy Region, ItalyMauro Turrini, Angelo Gardellini, Livia Beretta, et al.
Pharmacogenomics and Personalized Medicine|May 2, 2022
Therapeutic Management of Patients with FLT3 + Acute Myeloid Leukemia: Case Reports and Focus on Gilteritinib MonotherapyMonica Bocchia, Angelo Michele Carella, Antonino Mulè, et al.
Acta Haematologica|September 18, 2024
Bosutinib Treatment of Chronic Myeloid Leukemia in LombardyAlessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, et al.
Cancer|March 20, 2025
Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real-world setting: Interim results of the Italian observational study (ROMEI)Massimo Breccia, Francesca Palandri, Maurizio Martelli, et al.
Pageof 2